Table 5.
c‐Statistic | P Value* | Category Free NRI (95% CI) | Correctly Reclassified Higher (%) | Correctly Reclassified Lower (%) | IDI | P Value* | |
---|---|---|---|---|---|---|---|
Model 1 (n=1131) | |||||||
CHD events (n=256) | |||||||
Conventional risk factors | 0.625 | ||||||
+ln‐NGAL | 0.637 | 0.175 | 0.258 | 14.9 | 11.0 | 0.013 | <0.001 |
+Quartiles of NGAL | 0.641 | 0.135 | 0.329 | 23.2 | 9.8 | 0.017 | <0.001 |
+Above the median NGAL | 0.639 | 0.146 | 0.371 | 30.6 | 6.5 | 0.015 | <0.001 |
Model 2 (n=807) | |||||||
CHD events (n=170) | |||||||
Conventional risk factors | 0.637 | ||||||
+ln‐NGAL | 0.660 | 0.064 | 0.366 | 18.3 | 18.3 | 0.029 | <0.001 |
+Quartiles of NGAL | 0.662 | 0.078 | 0.451 | 31.7 | 13.4 | 0.029 | <0.001 |
+Above the median NGAL | 0.658 | 0.149 | 0.471 | 36.6 | 10.5 | 0.027 | <0.001 |
BMI indicates body mass index; CHD, coronary heart disease; IDI, integrated discrimination improvement; NGAL, neutrophil gelatinase‐associated lipocalin; NRI, net reclassification improvement.
Compared with conventional risk factors (Model 1 including age, BMI, current smoking, systolic blood pressure, prescription of antihypertensive medications, diabetes mellitus, and treatment code [calcium or placebo] or Model 2 including age, total cholesterol, high‐density lipoprotein cholesterol, current smoking, systolic blood pressure, prescription of antihypertensive medications, diabetes mellitus, and treatment code [calcium or placebo]).